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Abstract: New catalysts for important C–N bond formation are highly sought after. In this work, we
demonstrate the synthesis and viability of a new class of planar chiral [2.2]paracyclophane-based
bisoxazoline (BOX) ligands for the copper-catalyzed N–H insertion of α-diazocarbonyls into anilines.
The reaction features a wide substrate scope and moderate to excellent yields, and delivers the
valuable products at ambient conditions.
Keywords: [2.2]paracyclophane ligands; N–H insertion; α-diazocarbonyls; planar chirality;
copper catalysis
1. Introduction
The copper-catalyzed N–H insertion of carbenoids such as easily prepared α-diazocarbonyls is
a powerful method for the preparation of highly valuable bioactive molecules and pharmaceutical
products [1]. In the past decade, various enantioselective chelating ligands based on the bis(oxazoline)
motifs have been established for this transformation (Figure 1) [2–8].
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Figure 1. Representative classes of bisoxazoline-containing N,N-ligand systems used in asymmetric 
catalysis. 
While SpiroBOX IV (Error! Reference source not found.) combines axial chirality from the spiro 
backbone with the central chirality of the 2-substituted BOX moiety, [2.2]paracyclophane (PCP) 
Figure 1. Representative classes of bisoxazoline-containingN,N-ligand systems used in asymmetric catalysis.
While SpiroBOX IV (Figure 1) combines axial chirality from the spiro backbone with the central
chirality of the 2-substituted BOX moiety, [2.2]paracyclophane (PCP) exhibits planar chirality, which
has previously demonstrated remarkable performance as planar chiral ligand or chiral catalyst in
asymmetric catalysis [9]. Notable examples include the addition of alkyl, aryl, alkynyl, and alkenyl
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zinc reagents to aromatic and aliphatic aldehydes and imines that are catalyzed by PCP ligands[10–14].
The PCP core allows different substituents to be positioned regioselectively using carefully chosen
reaction parameters [15]. PCP displays planar chirality if only one substituent is introduced to one
of the two aromatic benzene rings (decks). If the other deck is substituted as well, especially with
both substituents being identical, only the pseudo-ortho and pseudo-meta PCP exhibit chirality, as
the other two PCP isomers show higher symmetry (Figure 2) [15]. Thus, the pseudo-ortho PCP
isomer is the most suitable for a chelating BOX ligand with PCP as the backbone – referred to here as
[2.2]paracyclophane-based bisoxazoline (PCPBOX).
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Figure 2. Achiral and chiral isomers of homodisubstituted PCP with the substituents on different decks.
The pseudo-ortho isomer is the most suitable candidate for PCPBOX ligands.
Mukai et al. recently rep rte hBOX that employed phenyl spacers bearing a sterically
demanding substituent bet een PCP and B X (Scheme 1). These PCPphBOX served as promising
chiral ligands for the asymmetric copper-catalyzed inter- and intra-molecular aromatic O–H insertion
reaction with up to 80%ee [16,17]. Mukai et al. additionally investigated PCPBOX ligands, with phenyl,
biphenyl, and without the phenyl as spacer groups for comparative studies. We thus set out to explore
the PCPBOX ligands in copper-catalyzed N–H insertion to expand on their versatility.
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2. Results
2.1. Synthesis
Access to pseudo-ortho disubstituted PCPs leads through the thermal or microwave-assisted
isomerization of the easily accessible pseudo-para dibromide of PCP [18]. In this way, pseudo-ortho
dibromide 2 was obtained in 70% yield. On this stage, chromatographic separation of the racemic 2
was achieved via a Chiralprak® AZ-H column (Scheme 2).
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The obtained (Rp)-2 and (Sp)-2 were subjected to a two-step lithiation-carboxylation procedure
to afford the enantiopure carboxylic acids 3 (Scheme 3). However, while the conversion of (Rp)-2
smoothly delivered (Rp)-3 in good yield, the conversion of (Sp)-2 left us with inconclusive results.
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With (Rp)-3 in hand, we proceeded with the PCPBOX synthesis by subjecting it to condensation
conditions with suitable amino alcohols to afford the respective hydroxyl amides. Under Appel
conditions, cyclization and dehydration is achieved to afford the enantiopure PCPBOXs 4a–c in
moderate to good yields (Scheme 4).
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between N–H insertion and β-hydride elimination (BHE) leads to a mixture of desired product 7 and
the olefinic product 8.
he initially teste ( e ) F6 complex shows good selectivity ( able 1, entry 1). Si le
copper (I) chlori e oes not eliver the esire pro ct at all (entry 2). o ering the te perat re to
roo te perat re increase the selectivity to an excellent ratio of 93:5 ith ( e ) F (entry 4).
hen -hy rogen lacking 6 as used (entry 7–10), product 9 was detected from the dimerization of
the α-diazocarbonyl 6b. Dropwise addition of 6b to the reaction mixture alleviated this issue for the
most part. With these optimized reaction conditions, the same copper source (Cu(MeCN)4PF6) leads to
excellent yields of 98% for the desired product 7b. Notably, in both cases the product was formed even
in the absence of the ligand 4 in 13% a 40% yield respectively.
The molecular structure of the N–H insertion product 7b was further confirmed unambiguously
by single crystal X-R ys structure analysis (Figure 3, for further etails see Electronic Supplementary
Information and cif-file, CCDC 1962906 (7b) contains the supplementary crystallographic data for this
paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre
via www.ccdc.cam.ac.uk/data_request/cif).
A series of other aniline derivatives and α-diazocarbonyls were investigated to further test the
substrate scope for this reaction. A wide range of products were obtained in short reaction times and in
good to excellent yields (Table 2). While unsubstituted phenyl rings as substituents gave the best yields
(entry 2), benzyl substituents also delivered the product in very good yield (entries 3–8). However,
a drop in yields was observed employing electron donating groups in the meta-position (entry 5).
This contrasts with findings of Zhou et al. showing no such drop for similar substitution patterns [2].
If non-aromatic anilines were used, no product formation could be observed (entries 11–12).
Molecules 2019, 24, 4122 5 of 14
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Entry 6 [Cu] T [°C] Yield [%] a Entry 6 [Cu] T [◦C]
Yield [%] a
7 8 9
1 6a Cu(MeCN)4PF6 40 77 18 n/a
2 CuCl 40 – 88 n/a
3 [CuOTf]2·Tol 40 58 38 n/a
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Table 2. Optimization of copper-catalyzed N–H insertion of diazocarbonyl 11 into aniline 10.
Molecules 2019, 24, x FOR PEER REVIEW 6 of 15 
 
R1
N2
OR2
O
R1
NH
OR2
O
5 mol% Cu(MeCN)4PF6
6 mol% (rac)-4
6 mol% NaBARF R3
CH2Cl2, r.t.
10
6a-j
R3-NH2
11  
Entry R1 R2 R3 Product Yield [%] a 
1 Bn Me Ph 7a 77 
2 Ph Me Ph 7b 98 
3 Me Bn Ph 7c 94 
4 Me Bn o-MeOPh 7d 82 
5 Me Bn m-MeOPh 7e 53 
6 Me Bn p-MeOPh 7f 70 
7 Me Bn o-MePh 7g 68 
8 Me Bn p-MePh 7h 70 
9 Me Ph Ph 7i 68 
10 Me tBu Ph 7j 74 
11 Me Bn c-C6H11 7k – 
12 Me Ph c-C6H11 7l – 
a Isolated yields. 
We turned our attention towards the enantioselective N–H insertion with unsaturated α-
diazocarbonyls. The products of this reaction are valuable intermediates that can be used in the total 
synthesis of biologically important products such as Rostratin B.-D [19]. The ligands discussed in 
Scheme 4 were tested with results summarized in Table 3. While only low yields of 22% were 
achieved with 5 mol% (Rp,S)-4a (Table 3, entry 1), this could be increased to 38% by using 10 mol% 
ligand. Dramatically increased yields were observed for the more sterically demanding (Rp,S)-4b and 
(Rp,S)-4c (entry 3–4). All these enantiopure ligands did not induce any considerable enantioselectivity 
as determined by chiral HPLC. This further verifies the observations obtained by Mukai et al. that 
the combination of planar and central chirality in PCPBOX ligands suffers from very low 
enantioinduction [17]. 
Table 3. Catalyst screening for the N–H insertion of unsaturated α-diazocarbonyl 13. 
10 mol% Cu(MeCN)4PF6
12 mol% Ligand
12 mol% NaBARF
CH2Cl2, r.t.
OMe
O
N2
Bn
O
NH2
+
13 5
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Entry Ligand Yield [%] a 
1 (Rp,S)-4a 22 
2 (Rp,S)-4a 38 
3 (Rp,S)-4b 80 
4 (Rp,S)-4c 88 
a Isolated yields. 
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Entry R1 R2 R3 Product Yield [%] a
1 Bn Me Ph 7a 77
2 Ph Me Ph 7b 98
3 Me Bn Ph 7c 94
4 Me Bn o-MeOPh 7d 82
5 Me Bn m-MeOPh 7e 53
6 Me Bn p-MeOPh 7f 70
7 Me Bn o-MePh 7g 68
8 Me Bn p-MePh 7h 70
9 Me Ph Ph 7i 68
10 Me tBu Ph 7j 74
11 Me Bn c-C6H11 7k –
12 Me Ph c-C6H11 7l –
a Isolated yields.
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3. Materials and Methods
Benzyl 2-diazopropanoate [20], Methyl 2-diazo-2-phenylacetate [21] and tert-Butyl
2-diazopropanoate [20] were prepared according to literature procedures.
4,16-Dibromo[2.2]paracyclophane (1)
A solution of Br2 (5.50 mL, 17.0 g, 106 mmol, 2.20 equiv.) in CH2Cl2 (50 mL) was prepared.
A suspension of iron powder (0.14 g, 2.4 mmol, 0.05 equiv.) in 6.25 mL of the Br2/CH2Cl2 solution was
diluted in 50 mL of CH2Cl2 and stirred at room temperature for 1 h. The solution was then brought to
reflux for 2 h. CH2Cl2 (50 mL) and [2.2]paracyclophane (10.0 g, 48.0 mmol, 1.00 equiv.) were added to
the mixture subsequently. After the remaining bromine solution was added dropwise over a period of
4 h, the mixture was stirred at room temperature for 3 d. Saturated Na2S2O3 solution was added and
the reaction mixture was stirred at room temperature until the bromine color disappeared. The organic
phase was separated and filtrated, the precipitate was recrystallized from hot toluene to obtain the title
product as an off-white solid, 5.40 g, 14.8 mmol, 31%.
1H-NMR (400 MHz, CDCl3) δ/ppm = 7.14 (dd, J = 7.8, 1.8 Hz, 2H, 2 × CArH), 6.51 (d, J = 1.8 Hz,
2H, 2 × CArH), 6.44 (d, J = 7.8 Hz, 2H, 2 × CArH), 3.50 (ddd, J = 12.8, 10.3, 2.0 Hz, 2H, 2 × CHPC), 3.16
(ddd, J = 12.1, 10.2, 4.6 Hz, 2H, 2 × CHPC), 2.95 (ddd, J = 12.1, 11.4, 2.0 Hz, 2H, 2 × CHPC), 2.85 (ddd,
J = 13.0, 10.6, 4.6 Hz, 2H, 2 × CHPC). 13C-NMR (101 MHz, CDCl3) δ/ppm = 141.3 (Cq, 2 × CAr), 138.6
(Cq, 2 × CAr), 137.4 (+, CH, 2 × CAr), 134.2 (+, CH, 2 × CAr), 128.4 (+, CH, 2 × CAr), 126.8 (Cq, 2 ×
CAr-Br), 35.5 (−, 2 × CH2), 32.9 51 (−, 2 × CH2). IR (ATR): v˜/cm−1 = 2932 (vw), 2849 (vw), 1895 (vw),
1583 (vw), 1532 (vw), 1474 (vw), 1449 (vw), 1432 (vw), 1390 (w), 1313 (vw), 1185 (vw), 1104 (vw), 1030
(w), 947 (vw), 899 (w), 839 (w), 855 (w), 830 (w), 706 (w), 669 (w), 647 (w), 522 (vw), 464 (w), 393 (vw).
MS (EI, 70 eV), m/z (%): 364/366/368 (3/6/3) [M]+, 184/182 (18/18) [M − C8H7Br]+, 104 (100) [C8H8]+.
HRMS (EI, C16H1479Br2) calc. 363.9457, found 363.9455.
(rac)-4,12-Dibromo[2.2]paracyclophane (rac)-2
In a 10 mL microwave vessel was placed 4,16-dibromo[2.2]paracyclophane (500 mg, 1.37 mmol,
1.00 equiv.) and DMF (1.00 mL). The device was programmed to heat the mixture to 180 ◦C with a
holding time set as 6 min. The maximum pressure for the system was set at 17.2 bar and the power
was set at 300 W. After cooling to room temperature, the mixture was diluted with DMF (2 mL) and
the precipitate was collected by filtration. The reaction was repeated under the same conditions until
all the starting material (5.00 g, 13.7 mmol, 1.00 equiv.) reacted. The combined filtrate was poured into
water (75 mL) and extracted with EtOAc (3 × 100 mL). The combined organic phase was washed with
water and brine, dried over Na2SO4 and concentrated under reduced pressure to give the title product
as a pale brown power, 3.50 g, 9.65 mmol, 70%.
Rf = 0.68 (c-Hex/EtOAc = 9:1). 1H-NMR (400 MHz, CDCl3) δ/ppm = 7.22 (d, J = 1.6 Hz, 2H, 2 ×
CArH), 6.56 (d, J = 7.8 Hz, 2H, 2 × CArH), 6.52 (dd, J = 7.9, 1.7 Hz, 2H, 2 × CArH), 3.47 (ddd, J = 13.3,
9.6, 2.2 Hz, 2H, 2 × CHPC), 3.10 (ddd, J = 13.0, 9.6, 6.8 Hz, 2H, 2 × CHPC), 3.06–2.94 (m, 2H, 2 × CHPC),
2.82 (ddd, J = 13.3, 10.1, 6.9 Hz, 2H, 2 × CHPC). 13C-NMR (101 MHz, CDCl3) δ/ppm = 141.3 (Cq, 2 ×
CAr), 138.7 (Cq, 2 × CAr), 135.0 (+, CH, 2 × CAr), 132.7 (+, CH, 2 × CAr), 131.7 (+, CH, 2 × CAr), 126.7 (Cq,
2 × CAr-Br), 35.8 (−, 2 × CH2), 32.5 (−, 2 × CH2). IR (ATR): v˜/cm−1 = 2923 (w), 2848 (w), 1583 (w), 1537
(w), 1474 (w), 1449 (w), 1431 (w), 1391 (m), 1272 (w), 1237 (w), 1201 (w), 1185 (w), 1030 (m), 902 (m),
858 (m), 785 (w), 705 (m), 644 (m), 475 (m). MS (70 eV, EI) m/z (%): 368/366/364 (22/43/22) [M]+, 288/286
(13/12) [M + H – Br]+, 184/182 (80/100) [M – C8H6Br]+, 104 (68) [C8H8]+. HRMS (EI, C16H1479Br2) calc.
363.9462, found 363.9461.
(Rp)-4,12-Dibromo[2.2]paracyclophane (Rp-2) / (Sp)-4,12-Dibromo[2.2]paracyclophane (Sp-2)
Separation of (rac)-4,12-dibromo[2.2]paracyclophane (2) was performed by semi-preparative chiral
HPLC. For details see Electronic Supporting Information.
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(Rp)-4,12-Dicarboxy[2.2]paracyclophane (Rp-3)
To a solution of (Rp)-4,12-dibromo[2.2]paracyclophane (1.50 g, 4.12 mmol, 1.00 equiv.) in abs.
THF (50 mL) was added 9.71 mL of t-butyllithium (1.7 M in pentane, 15.4 mmol, 4.00 equiv.) dropwise
at −78 ◦C. After stirring at −78 ◦C for 3 h, CO2 was bubbled through the solution via a long needle
under stirring for 2 h. The reaction mixture was then quenched with water and extracted with 1 M
NaOH solution (2 × 100 mL). The water phases were combined, washed with CH2Cl2 (50 mL) and
acidified with 6 M HCl until the solution tested acidic by litmus paper. The precipitate was filtrated,
washed with water and CH2Cl2. The title product was obtained after drying under high vacuum as
white powder, 640 mg, 3.14 mmol, 52%.
[α]D20 = −134 (c = 0.00203, EtOH). 1H-NMR (400 MHz, DMSO-d6) δ/ppm = 12.4 (s, 2H, 2 ×
COOH), 7.04 (d, J = 2.0 Hz, 2H, 2 × CArH), 6.78 (dd, J = 7.8, 1.9 Hz, 2H, 2 × CArH), 6.60 (d, J = 7.8 Hz,
2H, 2 × CArH), 4.04–3.88 (m, 2H, 2 × CArH), 3.15 (dd, J = 12.5, 9.8 Hz, 2H, 2 × CArH), 2.98 (ddd, J = 12.5,
9.6, 7.3 Hz, 2H, CArH), 2.81 (ddd, J = 12.3, 9.8, 7.3 Hz, 2H, 2 × CArH). 13C-NMR (101 MHz, DMSO-d6)
δ/ppm = 167.7 (Cq, 2 × COOH), 141.9 (Cq, 2 × CAr), 139.7 (Cq, 2 × CAr), 136.1 (+, CH, 2 × CAr), 135.9 (+,
CH, 2 × CAr), 133.3 (+, CH, 2 × CAr), 130.7 (Cq, 2 × CAr-COOH), 35.3 (−, CH2, 2 × CPC), 33.7 (−, CH2, 2
× CPC). IR (ATR): v˜/cm–1 = 2925 (w), 1674 (w), 1592 (w), 1556 (w), 1489 (vw), 1422 (w), 1300 (w), 1273
(w), 1203 (w), 1074 (w), 909 (w), 850 (vw), 797 (vw), 759 (vw), 717 (vw), 664 (w), 631 (w), 555 (vw),
518 (w), 426 (vw). MS (70 eV, EI) m/z (%): 296 (27) [M]+, 278 (100) [MH2O]+, 148 (83) [MC9H8O2]+.
HRMS (EI, C18H16O4) calc. 296.1049, found 296.1049. The analytical data match those reported in the
literature[22].
(Rp,S)-4,12-Bis(4′-isopropyloxazolin-2′yl)[2.2]paracyclophane (Rp,S)-4a
Thionyl chloride (1.0 mL) was added to (Rp,S)-4,12-dicarboxy[2.2]paracyclophane (250 mg,
0.840 mmol, 1.00 equiv.) and the resulting mixture was stirred at 100 ◦C for 90 min. After cooling
to room temperature, the excess thionyl chloride was removed under vacuum, the final traces were
washed with toluene (2 × 2 mL) and removed under vacuum. The resulting crude acetyl chloride was
dissolved in CH2Cl2 (5 mL) and cooled to 0 ◦C. A solution of S-Valinol (0.350 g, 3.36 mmol, 4.00 equiv.)
and Et3N (0.54 mL, 0.42 g, 4.20 mmol, 5.00 equiv.) in CH2Cl2 (1.0 mL) was added, the reaction mixture
was allowed to warm to room temperature and stirred for 24 h. 10 mL of CH2Cl2 was then added
and the solution was washed with aq. NaHCO3 solution (3.5% w/v, 2 × 10 mL) and brine (20 mL).
The organic phase was dried over MgSO4, filtered, concentrated, and dried under vacuum to give the
crude amide as light brown solid.
The crude amide was dissolved in CH3CN (5.0 mL), PPh3 (0.66 g, 2.52 mmol, 3.00 equiv.), CCl4
(0.770 mL, 1.23 g, 7.98 mmol, 9.50 equiv.) and Et3N (0.970 mL, 0.760 g, 7.56 mmol, 9.00 equiv.) were
added subsequently. After stirring at room temperature overnight, the solvent was removed under
reduced pressure, the resulting mixture was dissolved in CH2Cl2 and washed with H2O (2 × 10 mL),
the combined organic phase was washed with brine, dried over Na2SO4, filtrated and concentrated
under vacuum. The crude was purified via column chromatography (c-Hex/EtOAc = 9:1) to give the
title product as a pale yellow solid, 0.150 g, 0.350 mmol, 42%.
Rf = 0.34 (c-Hex/EtOAc = 9:1). 1H-NMR (400 MHz, CDCl3) δ/ppm = 7.09 (d, J = 1.9 Hz, 2H, 2 ×
CArH), 6.62 (dd, J = 7.9, 1.9 Hz, 2H, 2 × CArH), 6.54 (d, J = 7.8 Hz, 2H, 2 × CArH), 4.37 (ddd, J = 11.2,
9.5, 2.0 Hz, 2H, 2 × CHPC), 4.30 (dd, J = 5.8, 2.2 Hz, 2H, 2 × CH5′), 4.04 (dd, J = 8.6, 6.7 Hz, 2H, 2 ×
CH4
′
), 4.05–3.92 (m, 2H, 2 × CH5′), 3.24–3.16 (m, 2H, 2 × CHPC), 3.16–3.07 (m, 2H, 2 × CHPC), 2.82
(ddd, J = 12.6, 10.0, 7.1 Hz, 2H, 2 × CHPC), 1.95 (hept, J = 6.7 Hz, 2H, 2 × CH6′ ), 1.20 (d, J = 6.7 Hz, 6H,
CH7
′
), 1.06 (d, J = 6.7 Hz, 6H, CH7
′
). 13C-NMR (101 MHz, CDCl3) δ/ppm = 162.9 (Cq, 2 × C2′), 141.0
(Cq, 2 × CAr), 140.1 (Cq, 2 × CAr), 135.8 (+, CH, 2 × CAr), 134.8 (+, CH, 2 × CAr), 132.3 (+, CH, 2 × CAr),
128.2 (Cq, 2 × CAr), 73.8 (+, CH, 2 × C4′ ), 69.3 (−, CH2, 2 × C5′ ), 35.8 (−, CH2, 2 × CPC), 33.6 (+, CH, 2 ×
C6
′
), 33.6 (−, CH2, 2 × CPC), 19.7 (+, CH3, 2 × C7′ ), 19.2 (+, CH3, 2 × C7′ ). IR (ATR): v˜/cm–1 = 2955 (w),
1637 (m), 1590 (w), 1492 (w), 1468 (w), 1429 (w), 1384 (w), 1346 (w), 1303 (w), 1275 (w), 1258 (w), 1191
(w), 1172 (w), 1137 (w), 1115 (w), 1053 (m), 1026 (w), 984 (m), 933 (w), 907 (m), 889 (w), 822 (w), 749 (w),
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694 (w), 674 (w), 643 (w), 514 (w), 482 (vw), 389 (vw). MS (FAB, 3-NBA), m/z (%): 431 (100) [M + H]+,
500/488 (9/9) [C14H17NO2 + H]+. HRMS (FAB, C28H35O2N2, [M + H]+): calc. 431.2699, found 431.2701.
(Rp,S)-4,12-Bis(4′-tertbutyloxazolin-2′yl)[2.2]paracyclophane (Rp,S)-4b
Thionyl chloride (2.0 mL) was added to (Rp)-4,12-dicarboxy[2.2]paracyclophane (0.150 g,
0.510 mmol, 1.00 equiv.), after stirring at room temperature for 10 min, the mixture was heated
to 100 ◦C and stirred at this temperature for 90 min. The excess thionyl chloride was removed by
evaporation, the final traces were washed with toluene (2 × 2 mL). After drying under vacuum, the
resulting crude acid chloride was dissolved in abs. CH2Cl2 (5 mL) and cooled to 0 ◦C. A solution of
(S)-(+)-tert-leucinol (0.229 g, 2.04 mmol, 4.00 equiv.) and abs. Et3N (0.260 g, 0.360 mL, 2.55 mmol, 5.00
equiv.) in CH2Cl2 (1.0 mL) was added and the reaction mixture allowed to warm to room temperature
and stirred for 24 h. Water was then added (10 mL) and extracted with CH2Cl2 (3 × 10 mL), the
combined organic phase was washed with sat. NaHCO3 solution and brine (20 mL). The organic phase
was dried over MgSO4, filtrated, concentrated, and dried under vacuum. The crude was purified via
column chromatography (CH2Cl2/MeOH = 98:2→ 95:5) to give the intermediate amide. To a solution
of this amide (152 mg, 0.307 mmol, 1.00 equiv.) and PPh3 (282 mg, 1.08 mmol, 3.50 equiv.) in abs.
CH3CN (8.00 mL) was added triethyl amine (0.385 mL, 280 mg, 2.76 mmol, 9.00 equiv.) and CCl4
(0.281 mL, 449 mg, 2.92 mmol, 9.50 equiv.) under argon atmosphere. After stirring at room temperature
overnight, the solvent was removed under vacuum, the resulting crude was dissolved in CH2Cl2
and washed with brine, the organic phase was dried over Na2SO4, filtrated and concentrated under
vacuum. The resulting mixture was purified via column chromatography (c-Hex/EtOAc = 9:1) to give
the title product as colorless solid, 104 mg, 0.227 mmol, 44% over two steps.
Rf = 0.36 (c-Hex/EtOAc = 9:1). 1H-NMR (400 MHz, CDCl3) δ/ppm = 7.12 (d, J = 1.9 Hz, 2H, 2 ×
CArH), 6.64 (dd, J = 7.8, 1.9 Hz, 2H, 2 × CArH), 6.55 (d, J = 7.8 Hz, 2H, 2 × CArH), 4.33–4.24 (m, 2H, 2
× CH5′), 4.20 (td, J = 8.8, 3.7 Hz, 2H, 2 × CH4′), 4.17–4.08 (m, 4H, 2 × CH5′ + 2 × CHPC), 3.21–3.03
(m, 4H, 4 × CHPC), 2.86–2.68 (m, 2H, 2 × CHPC), 0.99 (s, 18H, CH7′). 13C-NMR (101 MHz, CDCl3)
δ/ppm = 162.9 (Cq, 2 × C2′), 141.0 (Cq, 2 × CAr), 140.2 (Cq, 2 × CAr), 135.6 (+, CH, 2 × CAr), 134.7 (+,
CH, 2 × CAr), 132.2 (+, CH, 2 × CAr), 128.0 (Cq, 2 × CAr), 74.2 (+, CH, 2 × C4′), 67.7 (−, CH2, 2 × C5′),
36.2 (−, CH2, 2 × CPC), 34.1 (−, CH2, 2 × CPC), 34.0 (Cq, 2 × C6′), 26.1 (+, CH3, 6 × C7′). IR (ATR):
v˜/cm−1 = 2951 (w), 2866 (w), 1638 (m), 1590 (w), 1477 (w), 1392 (w), 1350 (w), 1333 (w), 1303 (w), 1257
(w), 1191 (w), 1172 (w), 1113 (w), 1067 (w), 1047 (w), 1024 (w), 979 (m), 930 (w), 906 (w), 819 (w), 791
(w), 719 (w), 679 (w), 632 (w), 544 (vw), 513 (w). MS (FAB, 3-NBA), m/z (%): 459 (82) [M + H]+, 230 (75)
[C15H19NO + H]+. HRMS (FAB, C30H39O2N2, [M + H]+): calc. 459.3012, found 459.3011.
(Rp,S)-4,12-Bis(1′-phenyloxazolin-2′yl)[2.2]paracyclophane (Rp,S)-4c
Thionyl chloride (2.0 mL) was added to (Rp)-4,12-dicarboxy[2.2]paracyclophane (0.150 g,
0.510 mmol, 1.00 equiv.), after stirring at room temperature for 10 min, the mixture was heated
to 100 ◦C and stirred under this temperature for 90 min. The excess thionyl chloride was removed by
evaporation and the final traces were washed with toluene (2 × 2 mL). After drying under vacuum, the
resulting crude acid chloride was dissolved in abs. CH2Cl2 (5 mL) and cooled to 0 ◦C. A solution of
(S)-(+)-phenylglycinol (0.280 g, 2.04 mmol, 4.00 equiv.) and abs. Et3N (0.360 mL, 0.260 g, 2.55 mmol, 5.00
equiv.) in CH2Cl2 (1 mL) was added and the reaction mixture allowed to warm to room temperature
and stirred for 24 h. Water (10 mL) was then added, the water phase was extracted with CH2Cl2 (3 ×
10 mL) and the combined organic phase was washed with sat. NaHCO3 solution and brine (20 mL).
The organic phase was dried over MgSO4, filtered, concentrated, and dried in vacuum. The crude
was purified via column chromatography (CH2Cl2/MeOH = 98:2→ 95:5) to give the intermediate
amide. To a solution of this amide (200 mg, 0.374 mmol, 1.00 equiv.) and PPh3 (344 mg, 1.31 mmol,
3.50 equiv.) in abs. 10 mL of CH3CN was added Et3N (0.469 mL, 341 mg, 3.37 mmol, 9.00 equiv.)
and CCl4 (0.343 mL, 547 mg, 3.55 mmol, 9.50 equiv.) under argon atmosphere. After stirring at room
temperature overnight, the solvent was removed under vacuum, the resulting crude was dissolved in
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CH2Cl2 and washed with brine. The organic phase was dried over Na2SO4, filtrated and concentrated
under vacuum, the resulting mixture was purified via column chromatography (c-Hex/EtOAc = 9:1) to
give the title product as colorless solid, 177 mg, 0.355 mmol, 95%.
Rf = 0.14 (c-Hex/EtOAc = 9:1). 1H-NMR (500 MHz, CDCl3) δ/ppm = 7.40–7.29 (m, 12H, CH7 + 8
′ + 9
+ 2 × CArH), 6.70 (dd, J = 7.9, 1.9 Hz, 2H, 2 × CArH), 6.61 (d, J = 7.9 Hz, 2H, 2 × CArH), 5.47 (dd, J = 10.1,
8.2 Hz, 2H, 2 × CH5′), 4.65 (dd, J = 10.1, 8.2 Hz, 2H, 2 × CH5′), 4.44–4.25 (m, 2H, 2 × CHPC), 4.13 (t,
J = 8.2 Hz, 2H, 2 × CH4′), 3.22–3.14 (m, 4H, 4 × CHPC), 2.89–2.79 (m, 2H, 2 × CHPC). 13C-NMR (126
MHz, CDCl3) δ/ppm = 164.6 (Cq, 2 × C2′), 143.0 (Cq, 2 × C6′), 141.4 (Cq, 2 × CAr), 140.3 (Cq, 2 × CAr),
135.9 (+, CH, 2 × CAr), 135.1 (+, CH, 2 × CAr), 132.8 (+, CH, 2 × CAr), 128.8 (+, CH, 4 × C8′ ), 128.5 (Cq,
CH, 2 × CAr), 127.5 (+, CH, 2 × C9′ ), 126.9 (+, CH, 4 × C7′ ), 73.9 (+, CH, 2 × C4′ ), 70.7 (−, CH2, 2 × C5′ ),
36.4 (−, CH2, 2 × CPC), 34.2 (−, CH2, 2 × CPC). IR (ATR): v˜/cm–1 = 2922 (w), 1630 (m), 1589 (w), 1493
(w), 1448 (w), 1349 (w), 1296 (w), 1274 (w), 1245 (w), 1191 (w), 1172 (w), 1136 (vw), 1116 (vw), 1050 (w),
986 (w), 961 (w), 927 (w), 902 (w), 887 (w), 823 (w), 750 (w), 697 (w), 639 (w), 523 (w), 388 (vw). MS
(FAB, 3-NBA), m/z (%): 499 (100) [M + H]+, 250 (34) [C17H15NO + H]+. HRMS (FAB, C34H31O2N2, [M
+ H]+): calc 499.2386, found 499.2386.
Methyl 2-Phenyl-2-(phenylamino)acetate (7a)
General procedure (GP) was followed by adding phenyl-2-diazopropionate (17.6 mg, 1.00 mmol,
1.00 equiv.) and aniline (11.2 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated
Cu-(Rp,S)-4a catalyst. The product 7a was obtained via flash chromatography (c-Hex/EtOAc = 5:1) as
colorless solid, 23.6 mg, 0.98 mmol, 98%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.42 (d, J = 7.7 Hz, 2H, 2 × CArH), 7.27 (qd, J = 7.5, 6.4, 2.6
Hz, 3H, 3 × CArH), 7.04 (t, J = 7.9 Hz, 2H, 2 × CArH), 6.62 (t, J = 7.3 Hz, 1H, CArH), 6.48 (d, J = 7.7 Hz,
2H, 2 × CArH), 5.01 (d, J = 5.9 Hz, 1H, CHN), 4.88 (s, 1H, NH), 3.65 (s, 3H, OCH3).
The analytical data matches the data reported in the literature [23].
Methyl 2-phenyl-2-(phenylamino)acetate (7b)
GP was followed by adding phenyl-2-diazopropionate (17.6 mg, 1.00 mmol,1.00 equiv.) and
aniline (11.2 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product 7b was obtained via flash chromatography (c-Hex/EtOAc = 5:1) as colorless solid, 23.6 mg,
0.98 mmol, 98%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.42 (d, J = 7.7 Hz, 2H, 2 × CArH), 7.27 (qd, J = 7.5, 6.4, 2.6
Hz, 3H, 3 × CArH), 7.04 (t, J = 7.9 Hz, 2H, 2 × CArH), 6.62 (t, J = 7.3 Hz, 1H, CArH), 6.48 (d, J = 7.7 Hz,
2H, 2 × CArH), 5.01 (d, J = 5.9 Hz, 1H, CHN), 4.88 (s, 1H, NH), 3.65 (s, 3H, OCH3).
The analytical data matches the data reported in the literature[23].
General Procedure (GP): Copper-Catalyzed N–H Insertion
Cu(MeCN)4PF6 (5 mol%), ligand (6 mol%) and NaBArF (6 mol%) were added into an oven-dried
screw vial, evacuated, and backfilled with argon three times. After CH2Cl2 (1 mL) was injected
into the vial, the solution was stirred at 40 ◦C under argon atmosphere overnight. A solution of
α-diazopropionates (1.00 equiv.) and aniline (1.20 equiv.) in CH2Cl2 (1 mL) was added dropwise, the
mixture was stirred at room temperature for 2 h. The resulting mixture was dried under vacuum and
purified via column chromatography (c-Hex/EtOAc = 8:1 or pentane/Et2O = 5:1) to give the products
7a–j.
Benzyl phenylalaninate (7c)
GP was followed by adding benzyl 2-diazopropanoate (19.0 mg, 1.00 mmol, 1.00 equiv.) and
aniline (11.2 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained as a light-yellow solid (c-Hex/EtOAc = 4:1), 23.9 mg, 0.94 mmol, 94%.
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Rf = 0.33 (c-Hex/EtOAc = 5:1). 1H-NMR (300 MHz, CDCl3) δ/ppm = 7.31–7.16 (m, 5H, CH2Ph),
7.15–7.02 (m, 2H, 2 × CArH), 6.73 (tt, J = 7.3, 1.1 Hz, 1H, CArH), 6.63 (dd, J = 8.6, 1.2 Hz, 2H, 2 × CArH),
5.07 (s, 2H, CH2Ph), 4.14 (q, J = 7.0 Hz, 1H, CHN), 3.98 (s, 1H, NH), 1.42 (d, J = 7.0 Hz, 3H, CHCH3).
The analytical data matches the data reported in the literature [24].
Benzyl (2-methoxyphenyl)alaninate (7d)
GP was followed by adding benzyl 2-diazopropanoate (19.0 mg, 1.00 mmol, 1.00 equiv.) and
o-anisidine (14.8 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained via column chromatography (c-Hex/EtOAc = 5:1) as a light-yellow solid,
23.3 mg, 0.82 mmol, 82%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.40–7.06 (m, 5H, CH2Ph), 6.78–6.66 (m, 2H, 2 × CArH), 6.62
(ddd, J = 8.2, 7.2, 1.6 Hz, 1H, CArH), 6.44 (dd, J = 7.6, 1.6 Hz, 1H, CArH), 5.07 (s, 2H, CH2Ph), 4.64 (s,
1H, NH), 4.12 (q, J = 7.0 Hz, 1H, CHN), 3.76 (s, 3H, OCH3), 1.44 (d, J = 6.9 Hz, 3H, CHCH3). 13C-NMR
(75 MHz, CDCl3) δ/ppm = 174.5 (Cq, CO2Bn), 147.2 (Cq, CAr), 136.6 (Cq, CAr), 135.8 (Cq, CAr), 128.6 (+,
CH, 2 × CAr), 128.3 (+, CH, CAr), 128.2 (+, CH, 2 × CAr), 121.3 (+, CH, CAr), 117.7 (+, CH, CAr), 110.6
(+, CH, CAr), 109.9 (+, CH, CAr), 66.8 (−, CH2, CH2Ph), 55.5(+, CH3, OCH3), 52.0(+, CH, CHN), 18.9
(+, CH3).
The analytical data matches the data reported in the literature [24].
Benzyl (3-Methoxyphenyl)alaninate (7e)
GP was followed by adding benzyl 2-diazopropanoate (19.0 mg, 1.00 mmol, 1.00 equiv.) and
m-anisidine (14.8 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained via column chromatography (c-Hex/EtOAc = 5:1) as light-yellow solid, 15.1
mg, 53%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.39–7.27 (m, 5H, CH2Ph), 7.07 (t, J = 8.1 Hz, 1H, CArH),
6.32 (dd, J = 8.2, 2.3 Hz, 1H, CArH), 6.25–6.19 (m, 1H, CArH), 6.16 (t, J = 2.3 Hz, 1H, CArH), 5.16 (s, 2H,
CH2Ph), 4.19 (q, J = 6.9 Hz, 1H, CHN), 3.74 (s, 1H, NH), 1.48 (d, J = 6.9 Hz, 3H, CHCH3). 13C-NMR (75
MHz, CDCl3) δ/ppm = 174.3 (Cq, CO2Bn), 160.8 (Cq, CAr), 147.9 (Cq, CAr), 135.5 (Cq, CAr), 130.1 (+, CH,
CAr), 128.5 (+, CH, 2 × CAr), 128.3 (+, CH, CAr), 128.1 (+, CH, 2 × CAr), 106.3 (+, CH, CAr), 103.7 (+, CH,
CAr), 99.5 (+, CH, CAr), 66.8 (−, CH2, CH2Ph), 55.0 (+, CH3, OCH3), 52.0 (+, CH, CHN), 18.8 (+, CH3).
Benzyl (4-methoxyphenyl)alaninate (7f)
GP was followed by adding benzyl 2-diazopropanoate (19.0 mg, 1.00 mmol, 1.00 equiv.) and
p-anisidine (14.8 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained via column chromatography (c-Hex/EtOAc = 4:1) as light-yellow solid, 20.0
mg, 70%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.38–7.03 (m, 5H, CH2Ph), 6.72–6.61 (m, 2H, 2 × CArH), 6.51
(d, J = 9.0 Hz, 2H, 2 × CArH), 5.06 (s, 2H, CH2Ph), 4.04 (q, J = 6.9 Hz, 1H, CHN), 3.66 (s, 3H, CH3).
13C-NMR (75 MHz, CDCl3) δ/ppm = 175.3 (Cq, CO2Bn), 153.4 (Cq, CAr), 141.2 89 (Cq, CAr), 136.1 (Cq,
CAr), 129.1 (+, CH, 2 × CAr), 128.8 (+, CH, CAr), 128.6 (+, CH, 2 × CAr), 115.7 (+, CH, 2 × CAr), 115.4 (+,
CH, 2 × CAr), 67.2 (−, CH2, CH2Ph), 56.2 (+, CH3 OCH3,), 53.8 (+, CH, CHN), 19.5 (+, CH3).
The analytical data matches the data reported in the literature[25].
Benzyl o-tolylalaninate (7g)
GP was followed by adding benzyl 2-diazopropanoate (19.0 mg, 1.00 mmol, 1.00 equiv.) and
o-toluidine (12.9 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained via column chromatography (c-Hex/EtOAc = 5:1) as colorless solid, 18.3 mg,
0.68 mmol, 68%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.44–7.27 (m, 5H, CH2Ph), 7.15–7.05 (m, 2H, Ph), 6.72 (td,
J = 7.4, 1.2 Hz, 1H, Ph), 6.55 (dd, J = 8.4, 1.2 Hz, 1H, Ph), 5.19 (s, 2H, CH2Ph), 4.27 (q, J = 6.9 Hz, 1H,
CHCH3), 4.08 (s, 1H, NH), 2.21 (s, 3H, CH3), 1.55 (d, J = 6.9 Hz, 3H, CHCH3). 13C-NMR (75 MHz,
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CDCl3) δ/ppm = 174.7 (Cq, CO2Bn), 144.7 (Cq, CAr), 135.7 (Cq, CAr), 130.5 (Cq, CAr), 128.7 (+, CH, 2 ×
CAr), 128.4 (+, CH, CAr), 128.2 (+, CH, 2 × CAr), 127.2 (+, CH, CAr), 122.8 (+, CH, CAr), 118.0 (+, CH,
CAr), 110.5 (+, CH, CAr), 66.9 (−, CH2, CH2Ph), 52.1 (+, CH, CHN), 19.2 (+, CH3), 17.5 (+, CH3).
Benzyl p-tolylalaninate (7h)
GP was followed by adding benzyl 2-diazopropanoate (19.0 mg, 1.00 mmol, 1.00 equiv.) and
p-toluidine (12.9 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Sp,S)/(Rp,S)-4a
catalyst. The product was obtained via column chromatography (c-Hex/EtOAc = 4:1) as light-yellow
solid, 18.8 mg, 0.70 mmol, 70%.
Rf = 0.31 (c-Hex/EtOAc = 5:1). 1H-NMR (300 MHz, CDCl3) δ/ppm = 7.34–7.14 (m, 5H, CH2Ph),
6.89 (d, J=8.1 Hz, 2H, 2 × CArH), 6.45 (d, J = 8.4 Hz, 2H, 2 × CArH), 5.06 (s, 2H, CH2Ph), 4.09 (q, J = 7.0
Hz, 1H, CHN), 3.93 (s, 1H, NH), 2.16 (s, 3H, CH3), 1.39 (d, J = 6.9 Hz, 3H, CHCH3). 13C-NMR (75 MHz,
CDCl3) δ/ppm = 174.7 (Cq, CO2Bn), 144.4 (Cq, CAr), 135.7 (Cq, CAr), 129.9 (Cq, CAr), 128.6 (+, CH, 2 ×
CArH), 128.4 (+, CH, CArH), 128.2 (+, CH, 2 × CArH), 127.8 (+, CH, CArH), 113.9 (+, CH, CArH), 66.8
(−, CH2, CH2Ph), 52.6 (+, CH, CHN), 20.5 (+, CH3), 19.0 (+, CH3).
Phenyl phenylalaninate (7i)
GP was followed by adding methyl 2-diazo-2-phenylacetate (17.6 mg, 1.00 mmol, 1.00 equiv.) and
aniline (11.2 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained via column chromatography (c-Hex/EtOAc = 5:1) as light-yellow liquid,
16.3 mg, 0.68 mmol, 68%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.29 (td, J = 7.4, 6.8, 1.3 Hz, 2H, 2 × CArH), 7.20–7.03 (m, 3H,
3 × CArH), 6.98–6.87 (m, 2H, 2 × CArH), 6.72 (tt, J = 7.3, 1.1 Hz, 1H, CArH), 6.64 (dt, J = 7.7, 1.1 Hz, 2H,
2 × CArH), 4.32 (q, J = 7.0 Hz, 1H, CHN), 4.12 (s, 1H, NH), 1.58 (d, J = 6.9 Hz, 3H, CHCH3).
tert-Butyl phenylalaninate (7j)
GP was followed by adding tert-Butyl 2-diazopropanoate (15.6 mg, 1.00 mmol, 1.00 equiv.) and
aniline (11.2 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product was obtained via flash chromatography (c-Hex/EtOAc = 8:1) as a light-yellow liquid, 16.4
mg, 0.74 mmol, 74%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.21–7.11 (m, 3H, CArH), 6.73 (t, J = 7.3 Hz, 1H, CArH), 6.61
(d, J = 7.7 Hz, 2H, CArH), 4.02 (q, J = 6.9 Hz, 1H, CHN), 1.44 (s, 9H, C(CH3)3), 1.43 (d, J = 6.9 Hz, 3H). –
13C-NMR (75 MHz, CDCl3) δ/ppm = 174.3 (Cq, CO2tBu), 147.3 (Cq, CAr), 129.8 (+, CH, 2 × CAr), 118.6
(+, CH, CAr), 114.0 (+, CH, 2 × CAr), 82.0 (Cq, C(CH3)3), 53.1 (+, CH, CHNH), 28.5 (+, CH3, 3 × CH3),
19.4 (+, CH3, CHCH3).
The analytical data matches the data reported in the literature [26].
Methyl 2-phenyl-2-(phenylamino)acetate (14)
GP was followed by adding phenyl-2-diazopropionate (17.6 mg, 1.00 mmol,1.00 equiv.) and
aniline (11.2 mg, 1.20 mmol, 1.20 equiv.) to a suspension of in situ generated Cu-(Rp,S)-4a catalyst.
The product 7b was obtained via flash chromatography (c-Hex/EtOAc = 5:1) as colorless solid, 23.6 mg,
0.98 mmol, 98%.
1H-NMR (300 MHz, CDCl3) δ/ppm = 7.42 (d, J = 7.7 Hz, 2H, 2 × CArH), 7.27 (qd, J = 7.5, 6.4, 2.6
Hz, 3H, 3 × CArH), 7.04 (t, J = 7.9 Hz, 2H, 2 × CArH), 6.62 (t, J = 7.3 Hz, 1H, CArH), 6.48 (d, J = 7.7 Hz,
2H, 2 × CArH), 5.01 (d, J = 5.9 Hz, 1H, CHN), 4.88 (s, 1H, NH), 3.65 (s, 3H, OCH3).
The analytical data matches the data reported in the literature [23].
4. Conclusions
The successful N–H insertion of α-diazocarbonyls into anilines by copper catalysis with PCPBOX
ligands have been demonstrated. In this work, we showed the synthesis and catalytic application
of three different PCPBOX ligands. Their straight-forward synthesis renders them a very accessible
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ligand system. The N–H insertion into saturated anilines was demonstrated to afford moderate to
excellent yields with a wide substrate scope. The more sterically demanding PCPBOX ligands showed
very good yields in the N–H insertion with unsaturated anilines.
Supplementary Materials: All NMR spectroscopic analysis and other characterization data are available online.
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